Skip to main content
Erschienen in: Pediatric Nephrology 1/2021

25.06.2020 | Original Article

Prediction of kidney failure in children with chronic kidney disease and obstructive uropathy

verfasst von: Yuri V. Sebastião, Jennifer N. Cooper, Brian Becknell, Christina B. Ching, Daryl J. McLeod

Erschienen in: Pediatric Nephrology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Obstructive uropathy (OU) is a leading cause of pediatric kidney injury. Accurate prediction of kidney disease progression may improve clinical outcomes. We aimed to examine discrimination and accuracy of a validated kidney failure risk equation (KFRE), previously developed in adults, in children with OU.

Methods

We identified 118 children with OU and an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 in the Chronic Kidney Disease in Children study, a national, longitudinal, observational cohort. Each patient’s 5-year risk of kidney failure was estimated using baseline data and published parameters for the 4- and 8-variable KFREs. Discriminative ability of the KFRE was estimated using the C statistic for time-to-event analysis. Sensitivity and specificity were evaluated across varying risk thresholds.

Results

Among the 118 children, 100 (85%) were boys, with median baseline age of 10 years (interquartile range, 6–14). Median eGFR was 42 mL/min/1.73m 2 (32–53), with a median follow-up duration of 4.5 years (2.7–7.2); 23 patients (19.5%) developed kidney failure within 5 years. The 4-variable KFRE discriminated kidney failure risk with a C statistic of 0.75 (95% CI, 0.68–0.82). A 4-variable risk threshold of ≥ 30% yielded 82.6% sensitivity and 75.0% specificity. Results were similar using the 8-variable KFRE.

Conclusions

In children with OU, the KFRE discriminated the 5-year risk of kidney failure at C statistic values lower than previously published in adults but comparable with suboptimal values reported in the overall CKiD population. The 8-variable equation did not improve model discrimination or accuracy, suggesting the need for continued research into additional, disease-specific markers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Harambat J, Van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363–373CrossRef Harambat J, Van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363–373CrossRef
2.
Zurück zum Zitat Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583–591CrossRef Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583–591CrossRef
3.
Zurück zum Zitat Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS (2011) A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305:1553–1559CrossRef Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS (2011) A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305:1553–1559CrossRef
4.
Zurück zum Zitat Winnicki E, McCulloch CE, Mitsnefes MM, Furth SL, Warady BA, Ku E (2018) Use of the kidney failure risk equation to determine the risk of progression to end-stage renal disease in children with chronic kidney disease. JAMA Pediatr 172:174–180CrossRef Winnicki E, McCulloch CE, Mitsnefes MM, Furth SL, Warady BA, Ku E (2018) Use of the kidney failure risk equation to determine the risk of progression to end-stage renal disease in children with chronic kidney disease. JAMA Pediatr 172:174–180CrossRef
5.
Zurück zum Zitat Freedman AL, Johnson MP, Smith CA, Gonzalez R, Evans MI (1999) Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 354:374–377CrossRef Freedman AL, Johnson MP, Smith CA, Gonzalez R, Evans MI (1999) Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 354:374–377CrossRef
6.
Zurück zum Zitat Herbst KW, Tomlinson P, Lockwood G, Mosha MH, Wang Z, D’Alessandri-Silva C (2019) Survival and kidney outcomes of children with an early diagnosis of posterior urethral valves. Clin J Am Soc Nephrol 14:1572–1580CrossRef Herbst KW, Tomlinson P, Lockwood G, Mosha MH, Wang Z, D’Alessandri-Silva C (2019) Survival and kidney outcomes of children with an early diagnosis of posterior urethral valves. Clin J Am Soc Nephrol 14:1572–1580CrossRef
8.
Zurück zum Zitat Heikkilä J, Holmberg C, Kyllönen L, Rintala R, Taskinen S (2011) Long-term risk of end stage renal disease in patients with posterior urethral valves. J Urol 186:2392–2396CrossRef Heikkilä J, Holmberg C, Kyllönen L, Rintala R, Taskinen S (2011) Long-term risk of end stage renal disease in patients with posterior urethral valves. J Urol 186:2392–2396CrossRef
10.
Zurück zum Zitat Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Muñoz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006–1015CrossRef Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Muñoz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006–1015CrossRef
11.
Zurück zum Zitat Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR (2016) Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315:164–174CrossRef Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR (2016) Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315:164–174CrossRef
12.
Zurück zum Zitat Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WL, Lipkowitz MS, Wright JT, Chang AR, Astor BC (2015) Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis 65:394–402CrossRef Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WL, Lipkowitz MS, Wright JT, Chang AR, Astor BC (2015) Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK). Am J Kidney Dis 65:394–402CrossRef
15.
Zurück zum Zitat Demler OV, Paynter NP, Cook NR (2015) Tests of calibration and goodness-of-fit in the survival setting. Stat Med 34:1659–1680CrossRef Demler OV, Paynter NP, Cook NR (2015) Tests of calibration and goodness-of-fit in the survival setting. Stat Med 34:1659–1680CrossRef
17.
Zurück zum Zitat Furth SL, Pierce C, Hui WF, White CA, Wong CS, Schaefer F, Wühl E, Abraham AG, Warady BA, Samuels J, Furth S, Atkinson M, Wilson A, Quiroga A, Massengill S, Selewski D, Ferris M, Kogon A, Kaskel F, Lande M, Schwartz G, Saland J, Norwood V, Matoo T, Hidalgo G, Srivaths P, Carlson J, Langman C, Mendley S, John E, Upadhyay K, Seo-Mayer P, Patterson L, Parekh R, Robinson L, Weinstein A, Samsonov D, Kupferman J, Misurac J, Mongia A, Kiessling S, Sanchez-Kazi C, Dart A, Fathallah S, Claes D, Mitsnefes M, Blydt-Hansen T, Warady B, Greenbaum L, Flynn J, Wong C, Salusky I, Yadin O, Dell K, Jenkins R, Pan C, Ku E, Al-Uzri A, Jenkins R, Rodig N, Wong C, Davis K, Turman M, Bartosh S, Hastings C, Nayak A, Seikaly M, Benador N, Mak R, Wood E, Jenkins R, Lerner G, Barletta GM, Anarat A, Bakkaloglu A, Ozaltin F, Peco-Antic A, Querfeld U, Gellermann J, Sallay P, Drożdż D, Bonzel KE, Wingen AM, Żurowska A, Balasz I, Trivelli A, Perfumo F, Müller-Wiefel DE, Möller K, Offner G, Enke B, Wühl E, Hadtstein C, Mehls O, Schaefer F, Emre S, Caliskan S, Mir S, Wygoda S, Hohbach-Hohenfellner K, Jeck N, Klaus G, Ardissino G, Testa S, Montini G, Charbit M, Niaudet P, Caldas-Afonso A, Fernandes-Teixeira A, Dušek J, Matteucci MC, Picca S, Mastrostefano A, Wigger M, Berg UB, Celsi G, Fischbach M, Terzic J, Fydryk J, Urasinski T, Coppo R, Peruzzi L, Arbeiter K, Jankauskiené A, Grenda R, Litwin M, Janas R, Neuhaus TJ (2018) Estimating time to ESRD in children with CKD. Am J Kidney Dis 71:783–792. https://doi.org/10.1053/j.ajkd.2017.12.011CrossRefPubMedPubMedCentral Furth SL, Pierce C, Hui WF, White CA, Wong CS, Schaefer F, Wühl E, Abraham AG, Warady BA, Samuels J, Furth S, Atkinson M, Wilson A, Quiroga A, Massengill S, Selewski D, Ferris M, Kogon A, Kaskel F, Lande M, Schwartz G, Saland J, Norwood V, Matoo T, Hidalgo G, Srivaths P, Carlson J, Langman C, Mendley S, John E, Upadhyay K, Seo-Mayer P, Patterson L, Parekh R, Robinson L, Weinstein A, Samsonov D, Kupferman J, Misurac J, Mongia A, Kiessling S, Sanchez-Kazi C, Dart A, Fathallah S, Claes D, Mitsnefes M, Blydt-Hansen T, Warady B, Greenbaum L, Flynn J, Wong C, Salusky I, Yadin O, Dell K, Jenkins R, Pan C, Ku E, Al-Uzri A, Jenkins R, Rodig N, Wong C, Davis K, Turman M, Bartosh S, Hastings C, Nayak A, Seikaly M, Benador N, Mak R, Wood E, Jenkins R, Lerner G, Barletta GM, Anarat A, Bakkaloglu A, Ozaltin F, Peco-Antic A, Querfeld U, Gellermann J, Sallay P, Drożdż D, Bonzel KE, Wingen AM, Żurowska A, Balasz I, Trivelli A, Perfumo F, Müller-Wiefel DE, Möller K, Offner G, Enke B, Wühl E, Hadtstein C, Mehls O, Schaefer F, Emre S, Caliskan S, Mir S, Wygoda S, Hohbach-Hohenfellner K, Jeck N, Klaus G, Ardissino G, Testa S, Montini G, Charbit M, Niaudet P, Caldas-Afonso A, Fernandes-Teixeira A, Dušek J, Matteucci MC, Picca S, Mastrostefano A, Wigger M, Berg UB, Celsi G, Fischbach M, Terzic J, Fydryk J, Urasinski T, Coppo R, Peruzzi L, Arbeiter K, Jankauskiené A, Grenda R, Litwin M, Janas R, Neuhaus TJ (2018) Estimating time to ESRD in children with CKD. Am J Kidney Dis 71:783–792. https://​doi.​org/​10.​1053/​j.​ajkd.​2017.​12.​011CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Pencina MJ, D’Agostino RB (2015) Evaluating discrimination of risk prediction models: the C statistic. JAMA 314:1063–1064CrossRef Pencina MJ, D’Agostino RB (2015) Evaluating discrimination of risk prediction models: the C statistic. JAMA 314:1063–1064CrossRef
19.
Zurück zum Zitat Altman DG, Bland JM (1994) Statistics notes: diagnostic tests 2: predictive values. BMJ 309:102CrossRef Altman DG, Bland JM (1994) Statistics notes: diagnostic tests 2: predictive values. BMJ 309:102CrossRef
21.
Zurück zum Zitat Kamijo-Ikemori A, Sugaya T, Yoshida M, Hoshino S, Akatsu S, Yamazaki S, Kimura K, Shibagaki Y (2016) Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease. Clin Chem Lab Med 54:1645–1654. https://doi.org/10.1515/cclm-2015-1084CrossRefPubMed Kamijo-Ikemori A, Sugaya T, Yoshida M, Hoshino S, Akatsu S, Yamazaki S, Kimura K, Shibagaki Y (2016) Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease. Clin Chem Lab Med 54:1645–1654. https://​doi.​org/​10.​1515/​cclm-2015-1084CrossRefPubMed
Metadaten
Titel
Prediction of kidney failure in children with chronic kidney disease and obstructive uropathy
verfasst von
Yuri V. Sebastião
Jennifer N. Cooper
Brian Becknell
Christina B. Ching
Daryl J. McLeod
Publikationsdatum
25.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2021
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-020-04661-w

Weitere Artikel der Ausgabe 1/2021

Pediatric Nephrology 1/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.